Mark Horowitz

5.5k total citations · 1 hit paper
88 papers, 3.6k citations indexed

About

Mark Horowitz is a scholar working on Psychiatry and Mental health, Pharmacology and Electrical and Electronic Engineering. According to data from OpenAlex, Mark Horowitz has authored 88 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 29 papers in Pharmacology and 12 papers in Electrical and Electronic Engineering. Recurrent topics in Mark Horowitz's work include Treatment of Major Depression (27 papers), Schizophrenia research and treatment (23 papers) and Electroconvulsive Therapy Studies (16 papers). Mark Horowitz is often cited by papers focused on Treatment of Major Depression (27 papers), Schizophrenia research and treatment (23 papers) and Electroconvulsive Therapy Studies (16 papers). Mark Horowitz collaborates with scholars based in United Kingdom, United States and Denmark. Mark Horowitz's co-authors include David Taylor, Patricia A. Zunszain, Joanna Moncrieff, Carmine M. Pariante, Michael P. Hengartner, Ruth Cooper, Simone Amendola, Tom Stockmann, Donald Pellegrino and Hou Hai-yan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark Horowitz

79 papers receiving 3.5k citations

Hit Papers

The serotonin theory of d... 2022 2026 2023 2024 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The serotonin theory of depression: a systematic umbrella review of the evidence
    2022 490 citations Joanna Moncrieff, Ruth Cooper et al. Molecular Psychiatry profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Horowitz 1.0k 789 682 633 466 88 3.6k
Byung‐Joo Ham 617 0.6× 683 0.9× 734 1.1× 533 0.8× 735 1.6× 197 4.6k
Jun Chen 383 0.4× 560 0.7× 768 1.1× 237 0.4× 215 0.5× 181 2.8k
Francisco Moreno 661 0.7× 404 0.5× 605 0.9× 205 0.3× 852 1.8× 110 4.5k
Ian Reid 853 0.8× 340 0.4× 1.1k 1.6× 414 0.7× 869 1.9× 98 4.4k
Mehdi Ghasemi 571 0.6× 350 0.4× 647 0.9× 196 0.3× 1.0k 2.2× 126 3.3k
Francisco López‐Muñoz 636 0.6× 296 0.4× 1.0k 1.5× 107 0.2× 509 1.1× 273 3.7k
Michael Stanley 505 0.5× 382 0.5× 724 1.1× 334 0.5× 1.4k 3.1× 84 3.4k
Mauro Bianchi 414 0.4× 238 0.3× 467 0.7× 304 0.5× 798 1.7× 120 3.3k
Yonggui Yuan 458 0.5× 693 0.9× 1.3k 1.9× 410 0.6× 669 1.4× 292 6.4k
Yunlong Tan 168 0.2× 689 0.9× 824 1.2× 297 0.5× 333 0.7× 228 3.5k

Countries citing papers authored by Mark Horowitz

Since Specialization
Citations

This map shows the geographic impact of Mark Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Horowitz more than expected).

Fields of papers citing papers by Mark Horowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Horowitz. The network helps show where Mark Horowitz may publish in the future.

Co-authorship network of co-authors of Mark Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Horowitz. A scholar is included among the top collaborators of Mark Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Horowitz. Mark Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horowitz, Mark, James O’Neill, Fabrice Berna, & David Taylor. (2025). Not So Hasty: The Effect of Tapering Speed on Relapse May Still Be Important. Schizophrenia Bulletin.
2.
Juul, Sophie, Faiza Siddiqui, Caroline Barkholt Kamp, et al.. (2025). Challenges in the selection and measurement of outcomes in psychiatric trials. BMJ evidence-based medicine. 31(2). 75–78. 1 indexed citations
3.
Kamp, Caroline Barkholt, Sophie Juul, Faiza Siddiqui, et al.. (2025). The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis. BMC Psychiatry. 25(1). 67–67.
4.
5.
6.
Horowitz, Mark, Joshua E. J. Buckman, Rob Saunders, et al.. (2025). Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services. Psychiatry Research. 350. 116497–116497.
7.
Juul, Sophie, Faiza Siddiqui, Caroline Barkholt Kamp, et al.. (2024). Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialities. The Lancet Regional Health - Europe. 43. 100993–100993. 4 indexed citations
8.
Tan, Xuan, Yongbo Zheng, Na Zeng, et al.. (2024). Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review. Molecular Psychiatry. 30(5). 1758–1769. 10 indexed citations
9.
Higgins, Agnès, Pat Bracken, Toto Gronlund, et al.. (2024). Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnership. BMJ Open. 14(11). e088266–e088266. 4 indexed citations
10.
Kamp, Caroline Barkholt, Sophie Juul, Faiza Siddiqui, et al.. (2024). Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis. SHILAP Revista de lepidopterología. 27(1). e300730–e300730. 9 indexed citations
11.
Kamp, Caroline Barkholt, Sophie Juul, Faiza Siddiqui, et al.. (2024). The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Epidemiology and Psychiatric Sciences. 33. e51–e51. 3 indexed citations
12.
Taylor, David, et al.. (2024). Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs. SHILAP Revista de lepidopterología. 14. 1957190102–1957190102. 3 indexed citations
13.
McDonald, Suzanne, et al.. (2023). Acceptability and optimisation of resources to support antidepressant cessation: a qualitative think-aloud study with patients in Australian primary care. British Journal of General Practice. 74(739). e113–e119. 3 indexed citations
14.
15.
Calabrese, Gina M., Larry D. Mesner, Emily Farber, et al.. (2023). Single‐Cell Transcriptomics of Bone Marrow Stromal Cells in Diversity Outbred Mice: A Model for Population‐Level scRNA‐Seq Studies. Journal of Bone and Mineral Research. 38(9). 1350–1363. 3 indexed citations
16.
Morant, Nicola, Ruth Cooper, Jacki Stansfeld, et al.. (2023). Experiences of reduction and discontinuation of antipsychotics: a qualitative investigation within the RADAR trial. EClinicalMedicine. 64. 102135–102135. 12 indexed citations
17.
Horowitz, Mark & Patricia A. Zunszain. (2015). Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin. Annals of the New York Academy of Sciences. 1351(1). 68–79. 92 indexed citations
18.
Zunszain, Patricia A., et al.. (2013). Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties. Molecular Psychiatry. 18(12). 1236–1241. 87 indexed citations
19.
Horowitz, Mark, Patricia A. Zunszain, Christoph Anacker, Ksenia Musaelyan, & Carmine M. Pariante. (2013). Glucocorticoids and Inflammation: A Double-Headed Sword in Depression?. PubMed. 28. 127–143. 46 indexed citations
20.
Horowitz, Mark. (2011). A country under contract: early-Tudor England and the growth of a credit culture. SHILAP Revista de lepidopterología. 29(29). 75–86. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Byung‐Joo Ham Breakdown of academic impact, for papers by Jun Chen Breakdown of academic impact, for papers by Francisco Moreno Breakdown of academic impact, for papers by Ian Reid Breakdown of academic impact, for papers by Mehdi Ghasemi Breakdown of academic impact, for papers by Francisco López‐Muñoz Breakdown of academic impact, for papers by Michael Stanley Breakdown of academic impact, for papers by Mauro Bianchi Breakdown of academic impact, for papers by Yonggui Yuan Breakdown of academic impact, for papers by Yunlong Tan
Rankless by CCL
2026